What Is the Wegovy Pill? Everything You Need to Know

Direct Answer

Yes, a real Wegovy pill exists. The FDA approved Wegovy® pill (oral semaglutide, 25mg) on December 22, 2025, with a full nationwide launch on January 5, 2026. It's the first oral GLP-1 medication specifically approved for weight loss, distinct from the older oral semaglutide tablet (formerly Rybelsus, now marketed as the Ozempic tablet), which was approved specifically for diabetes at a lower dose.

Real Trial Results

In the OASIS 4 Phase 3 trial, a 64-week study of 307 adults with obesity or overweight, participants achieved an average 17% weight loss if they stayed on treatment throughout the trial, or roughly 14% regardless of whether they stayed on treatment the entire time. This is genuinely comparable to injectable Wegovy's real-world results.

Real Pricing

The starting dose (1.5mg) launched at $149 per month for eligible self-pay patients, with the 4mg dose also available at $149/month through April 15, 2026, then $199/month afterward. Novo Nordisk describes this as the most affordable self-pay price for a GLP-1 weight-loss medication to date.

Where It's Available

The Wegovy pill launched broadly through more than 70,000 US pharmacies, including CVS and Costco, plus select telehealth providers including Ro, LifeMD, Weight Watchers, and NovoCare Pharmacy, alongside GoodRx.

How This Differs From the Ozempic Tablet

Both are oral semaglutide, but they're genuinely different products with different approved uses and different dose ranges, the Ozempic tablet is approved for type 2 diabetes, while the Wegovy pill is specifically approved for weight management, at a higher dose (up to 25mg) than the diabetes-focused tablet.

Bottom Line

The Wegovy pill is a real, genuine, FDA-approved oral weight-loss option launched in January 2026, with real trial data and real, competitive pricing, a meaningful, needle-free alternative to injectable Wegovy for people who prefer it.

References

• Novo Nordisk: Wegovy Pill FDA Approval and Launch Announcement (December 2025 / January 2026)
• OASIS 4 Phase 3 Trial Results
• Scientific American: Wegovy Pill Becomes First Oral GLP-1 Weight-Loss Drug Approved in U.S.

Related Resources

• Wegovy Medication Guide
• How Do You Get GLP-1 Pills? A Real Guide to Oral Options
• Is Ro Legit? What to Know Before Ordering

Explore More

Explore the full GLP-1 Tracker knowledge base on DietApp.com

Get Started

Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 medication.

About DietApp.com

DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. This article is for general informational purposes and is not medical advice.